Xaira Therapeutics
PrivateLast Round
Series A
Apr 23, 2024
Est. Valuation
$2.7B
Total Funding Raised
$1B
Company Overview
Xaira Therapeutics is a biotechnology company that leverages artificial intelligence to enhance drug discovery and development through comprehensive product development and data generation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xaira Therapeutics Comparables
Compare Xaira Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insitro | 87% | |
| Valo Health | 83% | |
| Generate Biomedicines | 83% | |
Xaira Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 23, 2024 |
Key People
Founding team and executive leadership
Xaira Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Series A |
| SV Angel | Series A |
| New Enterprise Associates (NEA) | Series A |
| ARCH Venture Partners | Series A |
| F-Prime Capital | Series A |
| Risk and Return | Series A |
| Parker Institute for Cancer Immunotherapy | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 18, 2026
New model tests scaling laws in virtual cells.
- Jun 17, 2025
Launched X-Atlas/Orion, a large genome-wide Perturb-seq dataset.
Xaira Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xaira Therapeutics's valuation, stock price, and market status.